Literature DB >> 12900291

Evaluation of [18F]FHPG as PET tracer for HSVtk gene expression.

Erik F J de Vries1, Ingrid J van Dillen, Aren van Waarde, Antoon T M Willemsen, Willem Vaalburg, Nanno H Mulder, Geke A P Hospers.   

Abstract

In rats, the relationship between [(18)F]FHPG accumulation and HSVtk expression was studied with PET and autoradiography. [(18)F]FHPG distribution closely corresponded with HSVtk immunohistochemical staining. ROI analysis of tracer uptake 2 hours p.i. and Patlak graphical analysis were applied to quantify the PET data. For both analysis methods, the [(18)F]FHPG PET signal correlated well with the fraction of HSVtk expressing cells implanted, but showed a plateau when plotted against HSVtk protein levels. This might be due to rate limiting [(18)F]FHPG membrane transport.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900291     DOI: 10.1016/s0969-8051(03)00048-9

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  4 in total

Review 1.  PET molecular imaging in stem cell therapy for neurological diseases.

Authors:  Jiachuan Wang; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

Review 2.  Gene therapy imaging in patients for oncological applications.

Authors:  Iván Peñuelas; Uwe Haberkorn; Shahriar Yaghoubi; Sanjiv S Gambhir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

3.  [18F]FHPG positron emission tomography for detection of herpes simplex virus (HSV) in experimental HSV encephalitis.

Authors:  A R Buursma; E F J de Vries; J Garssen; D Kegler; A van Waarde; J Schirm; G A P Hospers; N H Mulder; W Vaalburg; H C Klein
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport.

Authors:  A R Buursma; I J van Dillen; A van Waarde; W Vaalburg; G A P Hospers; N H Mulder; E F J de Vries
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.